A Community-based HPV screening implementation in Low-Income countries

01 September 2021 → 31 August 2026
European funding: framework programme, Regional and community funding: Special Research Fund
Research disciplines
  • Medical and health sciences
    • Public health care not elsewhere classified
cervical cancer
Other information
Project description

Global implementation of cancer screening can be hindered by differences in cultures and available resources between countries. The EU-funded CHILI project will address this challenge by determining the acceptability, feasibility and cost-effectiveness of the ELEVATE cervical cancer screening tool for women in low-income countries. This portable, battery-powered device comprises a human papillomavirus DNA test and a proteomic biomarkers detection sensor. Social scientists will investigate current screening practices and draw up a tailored strategy embedded in the current health system, while engineers will validate the self-testing device and adapt it for large-scale manufacturing at an affordable cost. Public health specialists and health economists will then evaluate the implementation of the screening tool to determine its suitability and cost-effectiveness.

Role of Ghent University
Ghent University coordinates the overall project. In addition, researchers from the International Centre for Reproductive Health (ICRH) and Center for MicroSystems Technology (CMST) work closely together to fulfil the various tasks of the project in Belgium.